These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9886796)

  • 1. Identification of complement activators and elucidation of the fate of complement activation products during extracorporeal plasma purification therapy.
    Fadul JE; Alarabi AA; Wikström B; Danielson BG; Nilsson B
    J Clin Apher; 1998; 13(4):167-73. PubMed ID: 9886796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation as a cause of transient hypotension during plasmapheresis.
    Shiga Y; Fujihara K; Onodera H; Nagata T; Itoyama Y
    Artif Organs; 1998 Dec; 22(12):1067-9. PubMed ID: 9876101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in plasma retinol in unconjugated hyperbilirubinemia treated with bilirubin adsorption using an anion-exchange resin.
    Ihara H; Shino Y; Hashizume N; Aoki T; Suzuki Y; Igarasi Y; Naito C
    J Nutr Sci Vitaminol (Tokyo); 1998 Apr; 44(2):329-36. PubMed ID: 9675713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoadsorption therapy for myasthenia gravis: study on the adsorption capacity of an immunoadsorption column].
    Yeh JH; Chiu HC
    J Microbiol Immunol Infect; 1999 Jun; 32(2):121-5. PubMed ID: 11565565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement profile and activation mechanisms by different LDL apheresis systems.
    Hovland A; Hardersen R; Nielsen EW; Enebakk T; Christiansen D; Ludviksen JK; Mollnes TE; Lappegård KT
    Acta Biomater; 2012 Jul; 8(6):2288-96. PubMed ID: 22373816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation during tryptophan immunoadsorption treatment.
    Alarabi AA; Nilsson B; Nilsson U; Wikström B; Danielson BG
    Artif Organs; 1993 Sep; 17(9):782-6. PubMed ID: 8240071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement metabolism during membrane plasma separation.
    McLeod BC; Viernes A; Sassetti RJ
    Artif Organs; 1983 Nov; 7(4):443-9. PubMed ID: 6651583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of four plasmapheresis membranes in patients treated for hypercholesterolemia.
    Böhler J; Donauer K; Köster W; Schollmeyer PJ; Wieland H; Hörl WH
    Am J Nephrol; 1991; 11(6):479-85. PubMed ID: 1819214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of inverse plasma filtration on complement activation in porcine blood.
    Haltern C; Kirschfink M; Rossaint R; Unger JK
    Artif Organs; 2005 Apr; 29(4):306-12. PubMed ID: 15787625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia.
    Stoffel W; Borberg H; Greve V
    Lancet; 1981 Nov; 2(8254):1005-7. PubMed ID: 6118475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal albumin dialysis.
    Abe T; Shono M; Kodama T; Kita Y; Fukagawa M; Akizawa T
    Ther Apher Dial; 2004 Jun; 8(3):217-22. PubMed ID: 15154874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological effects of therapeutic immunoadsorption with respect to biocompatibility.
    Kadar JG; Parusel M; Spaeth PJ
    Transfus Sci; 1998 Mar; 19 Suppl():9-23. PubMed ID: 10178699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term effects on serum lipoproteins by three different techniques of apheresis.
    Richter WO; Donner MG; Schwandt P
    Artif Organs; 1996 Apr; 20(4):311-7. PubMed ID: 8860712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation and depletion during LDL-apheresis by heparin-induced extracorporeal LDL-precipitation (HELP).
    Würzner R; Schuff-Werner P; Franzke A; Nitze R; Oppermann M; Armstrong VW; Eisenhauer T; Seidel D; Götze O
    Eur J Clin Invest; 1991 Jun; 21(3):288-94. PubMed ID: 1909632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel system of LDL apheresis combining a centrifugal plasma separator with a specific LDL adsorption column.
    Nakajima T; Nakamura T; Funahashi T; Kanai H; Kurata Y; Matsuzawa Y; Tarui S
    Atherosclerosis; 1988 Oct; 73(2-3):143-8. PubMed ID: 3190816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The "Fractionated Plasma Separation and Adsorption system" (FPSA), a new membrane absorption-assisted adjunctive extracorporeal blood purification system for liver failure].
    Strobl W; Vogt G; Mitteregger R; Schönhofen M; Gerner FJ; Falkenhagen D
    Biomed Tech (Berl); 1998; 43 Suppl():168-9. PubMed ID: 9859309
    [No Abstract]   [Full Text] [Related]  

  • 18. LDL apheresis activates the complement system and the cytokine network, whereas PCSK9 inhibition with evolocumab induces no inflammatory response.
    Lappegård KT; Enebakk T; Thunhaug H; Ludviksen JK; Mollnes TE; Hovland A
    J Clin Lipidol; 2016; 10(6):1481-1487. PubMed ID: 27919366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood purification methods for treatment of organ failure in patients with severe pancreatitis].
    Pupelis G; Austrums E; Snippe K
    Zentralbl Chir; 2001 Oct; 126(10):780-4. PubMed ID: 11727187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation during plasma production depends on the apheresis technique.
    Sonntag J; Emeis M; Vornwald A; Strauss E; Maier RF
    Transfus Med; 1998 Sep; 8(3):205-8. PubMed ID: 9800292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.